Evidence map›Paper›PMID 36615726›Full record

ReviewNutrients2022

Branched-Chain Amino Acids and Insulin Resistance, from Protein Supply to Diet-Induced Obesity.

Jean-Pascal De Bandt, Xavier Coumoul, Robert Barouki

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 67 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Observational
  4. Article
  5. Review
  6. Article
  7. Article
  8. The Complex Relation of Branched-Chain Amino Acids and Inflammation in the Obesity and Diabetes Context.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jean-Pascal De BandtINSERM UMR-S 1124-T3S, Environmental Toxicity, Therapeutic Targets, Cellular Signaling & Biomarkers, Faculté des Sciences, Université Paris Cité, UFR des Sciences Fondamentales et Biomédicales, 75006 Paris, France.ORCID 0000-0001-9292-6510
Xavier CoumoulINSERM UMR-S 1124-T3S, Environmental Toxicity, Therapeutic Targets, Cellular Signaling & Biomarkers, Faculté des Sciences, Université Paris Cité, UFR des Sciences Fondamentales et Biomédicales, 75006 Paris, France.ORCID 0000-0003-2928-9648
Robert BaroukiINSERM UMR-S 1124-T3S, Environmental Toxicity, Therapeutic Targets, Cellular Signaling & Biomarkers, Faculté des Sciences, Université Paris Cité, UFR des Sciences Fondamentales et Biomédicales, 75006 Paris, France.
Inserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For more than a decade, there has been a wide debate about the branched-chain amino acids (BCAA) leucine, valine, and isoleucine, with, on the one hand, the supporters of their anabolic effects and, on the other hand, those who suspect them of promoting insulin resistance. Indeed, the role of leucine in the postprandial activation of protein synthesis has been clearly established, even though supplementation studies aimed at taking advantage of this property are rather disappointing. Furthermore, there is ample evidence of an association between the elevation of their plasma concentrations and insulin resistance or the risk of developing type 2 diabetes, although there are many confounding factors, starting with the level of animal protein consumption. After a summary of their metabolism and anabolic properties, we analyze in this review the factors likely to increase the plasma concentrations of BCAAs, including insulin-resistance. After an analysis of supplementation or restriction studies in search of a direct role of BCAAs in insulin resistance, we discuss an indirect role through some of their metabolites: branched-chain keto acids, C3 and C5 acylcarnitines, and hydroxyisobutyrate. Overall, given the importance of insulin in the metabolism of these amino acids, it is very likely that small alterations in insulin sensitivity are responsible for a reduction in their catabolism long before the onset of impaired glucose tolerance.

Indexed as

Diabetes Mellitus, Type 2Insulin ResistanceAmino Acids, Branched-ChainAnimalsBlood GlucoseDietInsulinLeucineObesityAmino Acids, Branched-ChainBlood GlucoseInsulinLeucineacylcarnitinebranched-chain keto acidsglucose tolerancehydroxyisobutyrateisoleucineleucineprotein consumptiontype 2 diabetesvaline

Identifiers

PMID36615726
PMCPMC9824001
OpenAlexW4313244424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.